EARNEST Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-162
Closed -$32.4K 450
2023
Q3
$32.4K Hold
162
﹤0.01% 415
2023
Q2
$30K Hold
162
﹤0.01% 409
2023
Q1
$31K Hold
162
﹤0.01% 397
2022
Q4
$27.2K Hold
162
﹤0.01% 423
2022
Q3
$29K Hold
162
﹤0.01% 386
2022
Q2
$33K Hold
162
﹤0.01% 380
2022
Q1
$39K Hold
162
﹤0.01% 365
2021
Q4
$37K Hold
162
﹤0.01% 376
2021
Q3
$31K Hold
162
﹤0.01% 397
2021
Q2
$34K Hold
162
﹤0.01% 383
2021
Q1
$33K Hold
162
﹤0.01% 384
2020
Q4
$29K Hold
162
﹤0.01% 386
2020
Q3
$27K Hold
162
﹤0.01% 361
2020
Q2
$26K Hold
162
﹤0.01% 359
2020
Q1
$28K Hold
162
﹤0.01% 342
2019
Q4
$33K Hold
162
﹤0.01% 362
2019
Q3
$34K Hold
162
﹤0.01% 352
2019
Q2
$31K Hold
162
﹤0.01% 367
2019
Q1
$27K Hold
162
﹤0.01% 389
2018
Q4
$30K Hold
162
﹤0.01% 358
2018
Q3
$28K Hold
162
﹤0.01% 376
2018
Q2
$27K Hold
162
﹤0.01% 381
2018
Q1
$26K Hold
162
﹤0.01% 386
2017
Q4
$24K Buy
+162
New +$23.1K ﹤0.01% 387
2017
Q1
Sell
-162
Closed -$19K 377
2016
Q4
$19K Buy
+162
New +$18K ﹤0.01% 409

Other funds holding CME

EARNEST Partners's CME Position: Q4 2023 in Review

EARNEST Partners sold out of CME Group (CME) in Q4 2023, closing a stake of 162 shares — an estimated $32.4K sold.

EARNEST Partners first reported a position in CME in Q4 2016 and held it in 25 quarters. The position peaked at $39K in Q1 2022. 1,364 funds tracked by Wall St. Rank hold CME as of Q4 2023.

  • EARNEST Partners reported no remaining CME Group position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 162 CME Group shares in Q4 2023, an estimated $32.4K.
  • EARNEST Partners first reported a position in CME Group in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's CME Group position peaked at $39K in Q1 2022.
  • 1,364 funds tracked by Wall St. Rank held CME Group as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.